John J Engemann

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
    John J Engemann
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Clin Infect Dis 36:592-8. 2003
  2. ncbi request reprint Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis
    John J Engemann
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Infect Control Hosp Epidemiol 26:534-9. 2005
  3. ncbi request reprint Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia
    Jula K Inrig
    Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27705, USA
    Clin J Am Soc Nephrol 1:518-24. 2006
  4. ncbi request reprint Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost
    Sarah A McGarry
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Infect Control Hosp Epidemiol 25:461-7. 2004
  5. pmc Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae
    Deverick J Anderson
    Duke University Medical Center, Division of Infectious Disease, DUMC Box 3824, Durham, NC 27710, USA
    Antimicrob Agents Chemother 50:1715-20. 2006
  6. ncbi request reprint Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 44:190-6. 2007
  7. pmc Reference group choice and antibiotic resistance outcomes
    Keith S Kaye
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Emerg Infect Dis 10:1125-8. 2004
  8. doi request reprint Mortality and time to extubation in severe hospital-acquired pneumonia
    Sarah M Connelly
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Am J Infect Control 37:143-9. 2009
  9. ncbi request reprint Favorable impact of an infection control network on nosocomial infection rates in community hospitals
    Keith S Kaye
    Department of Medicine and Infection Control, Duke University Medical Center, Durham, NC 27710, USA
    Infect Control Hosp Epidemiol 27:228-32. 2006
  10. ncbi request reprint Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread
    Jay R McDonald
    Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA
    Pediatr Infect Dis J 26:678-83. 2007

Detail Information

Publications21

  1. ncbi request reprint Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
    John J Engemann
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Clin Infect Dis 36:592-8. 2003
    ..Methicillin resistance is independently associated with increased mortality and hospital charges among patients with S. aureus SSI...
  2. ncbi request reprint Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis
    John J Engemann
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Infect Control Hosp Epidemiol 26:534-9. 2005
    ..To examine the clinical outcomes and costs associated with Staphylococcus aureus bacteremia among hemodialysis-dependent patients...
  3. ncbi request reprint Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia
    Jula K Inrig
    Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27705, USA
    Clin J Am Soc Nephrol 1:518-24. 2006
    ..Twelve-week mortality and costs that are associated with an episode of SAB are high in hemodialysis patients, regardless of vascular access type. Efforts should focus on the prevention of SAB in this high-risk group...
  4. ncbi request reprint Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost
    Sarah A McGarry
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Infect Control Hosp Epidemiol 25:461-7. 2004
    ..aureus SSI...
  5. pmc Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae
    Deverick J Anderson
    Duke University Medical Center, Division of Infectious Disease, DUMC Box 3824, Durham, NC 27710, USA
    Antimicrob Agents Chemother 50:1715-20. 2006
    ..07 to 10.3). Thus, among patients with BSI due to CAZ-R K. pneumoniae, a delay in the initiation of effective therapy of greater than 72 h after BSI was associated with a >3-fold increase in mortality risk...
  6. ncbi request reprint Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 44:190-6. 2007
    ..Clinical outcomes resulting from such a therapeutic strategy have not been well defined...
  7. pmc Reference group choice and antibiotic resistance outcomes
    Keith S Kaye
    Duke University Medical Center, Durham, North Carolina 27710, USA
    Emerg Infect Dis 10:1125-8. 2004
    ..Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used...
  8. doi request reprint Mortality and time to extubation in severe hospital-acquired pneumonia
    Sarah M Connelly
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Am J Infect Control 37:143-9. 2009
    ..This study examined predictors of in-hospital mortality and time to extubation among patients with acute, severe hospital-acquired pneumonia (HAP) managed in the intensive care unit (ICU)...
  9. ncbi request reprint Favorable impact of an infection control network on nosocomial infection rates in community hospitals
    Keith S Kaye
    Department of Medicine and Infection Control, Duke University Medical Center, Durham, NC 27710, USA
    Infect Control Hosp Epidemiol 27:228-32. 2006
    ..To describe an infection control network (the Duke Infection Control Outreach Network [DICON]) and its impact on nosocomial infection rates in community hospitals...
  10. ncbi request reprint Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread
    Jay R McDonald
    Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA
    Pediatr Infect Dis J 26:678-83. 2007
    ..After surveillance surveys documented the absence of methicillin-resistant Staphylococcus aureus (MRSA) in our intensive care nursery, an outbreak of MRSA infection occurred there during a 7-month period in 2005...
  11. doi request reprint Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study
    V H Chu
    Duke University Medical Center, Durham, NC 27710, USA
    Heart 95:570-6. 2009
    ..To describe the contemporary features of coagulase-negative staphylococcal (CoNS) prosthetic valve endocarditis (PVE)...
  12. pmc Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa
    Keith S Kaye
    Duke University Medical Center, Durham, NC 27710, USA
    Antimicrob Agents Chemother 50:2192-6. 2006
    ..6; 95% CI = 0.4 to 0.9), whereas ciprofloxacin had no significant effect (OR = 1.0; 95% CI = 0.6 to 1.8). In conclusion, the use of levofloxacin, but not ciprofloxacin, was associated with isolation of QR P. aeruginosa...
  13. ncbi request reprint Early surgery in patients with infective endocarditis: a propensity score analysis
    Olcay Aksoy
    Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Clin Infect Dis 44:364-72. 2007
    ..Largely because of these limitations, the role of surgery in long-term survival has not been adequately studied...
  14. ncbi request reprint Leptotrichia endocarditis: report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases
    L B Caram
    Division of Infectious Diseases, Duke University Medical Center, Box 3824, Durham, NC 27710, USA
    Eur J Clin Microbiol Infect Dis 27:139-43. 2008
    ..goodfellowii sp. nov. Both cases were identified using 16S rRNA gene sequencing. Review of the English literature revealed only two other cases of Leptotrichia sp. endocarditis...
  15. ncbi request reprint Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis
    Jason E Stout
    Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
    Am J Respir Crit Care Med 167:824-7. 2003
    ..The rifampin/pyrazinamide regimen for latent tuberculosis infection may be useful for high-risk, traditionally nonadherent patient groups, but careful monitoring for toxicity is required...
  16. ncbi request reprint Control of nosocomial acquisition of vancomycin-resistant Enterococcus through active surveillance of hemodialysis patients
    R Neal Axon
    Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Infect Control Hosp Epidemiol 25:436-8. 2004
    ..05). To assess the effectiveness of active surveillance, patients undergoing active surveillance should be analyzed separately from other patients...
  17. doi request reprint Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection
    David P Holland
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Pharmacotherapy 29:503-10. 2009
    ..To determine the feasibility of therapeutic drug monitoring for adjusting low serum antimycobacterial concentrations in patients with both tuberculosis and advanced human immunodeficiency virus (HIV)...
  18. pmc Candida infective endocarditis
    J W Baddley
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Eur J Clin Microbiol Infect Dis 27:519-29. 2008
    ..Indications for surgical intervention are different and mortality is increased. Newer antifungal treatment options are increasingly used. Large, multi-center studies are needed to help better define Candida IE...
  19. ncbi request reprint Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management
    Keith S Kaye
    Department of Medicine, Duke University Medical Center, Box 3152, Durham, NC 27710, USA
    Infect Dis Clin North Am 18:467-511, viii. 2004
    ..This article reviews the epidemiology, molecular mechanisms of resistance, and treatment options for pathogens resistant to antimicrobial drugs...
  20. ncbi request reprint Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia
    Shelby D Reed
    Center for Clinical and Genetic Economics, USA
    Infect Control Hosp Epidemiol 26:175-83. 2005
    ..We compared costs and outcomes of methicillin resistance in patients with S. aureus bacteremia and a single chronic condition...
  21. ncbi request reprint Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals
    Jay R McDonald
    Infect Control Hosp Epidemiol 25:622. 2004